Corporate Banner
Satellite Banner
Technology Networks Header
Friday, August 01, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Merck Millipore Launches Lockable ICRplus Settle Plates
Wednesday, October 30, 2013
Suitable for use in isolators and clean rooms.

New Innovative Touch Screen Peristaltic Pump
Friday, October 18, 2013
New Allegro™ Peristaltic Pump System is available in three models.

Separate Targeted Carbonyl Compounds in Less Than 10 Minutes
Friday, October 18, 2013
Determination of carbonyl compounds by combining HPLC methods with ultraviolet detection.

Shimadzu Launches New Series of Planar Diffraction Gratings for Laser System Applications
Tuesday, October 15, 2013
The customizable ‘LA series’ planar gratings offer a high diffraction efficiency of more than 90% for near infra-red wavelength laser compressor applications.

PTR-TOF Technology Contributes to CLOUD Experiment at CERN
Friday, October 11, 2013
Scientists publish new results concerning cloud formation in “Nature”.

Hamamatsu Introduces New S12572 Series of MPPC Devices
Tuesday, October 08, 2013
New improved MPPC for general photon counting applications.

New Improved MPPC for General Photon Counting Applications
Tuesday, October 08, 2013
Hamamatsu introduces new S12571 series of multi-pixel photon counter devices.

Waters Introduces the ACQUITY QDa Detector
Monday, October 07, 2013
The Waters® ACQUITY QDa™ Detector is the first mass detector to bring high-quality, mass spectral data to chromatographic separations.

Product Launches at Lab Innovations 2013
Tuesday, October 01, 2013
Over 40% of exhibitors at Lab Innovations 2013 are using the show to launch new technologies and services into the UK.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 359
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv